1-(Bromomethyl)-4-methoxybenzene (stabilised with K2CO3 2-5%), 95.0%, 1g

2-Cyclohexylpropane-1,3-diol, 98%, 1g

4-Chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine, 95.0%, 5g

tert-Butyl (1-amino-2-methyl-1-oxopropan-2-yl)carbamate, 95.0%, 2g

Methyl 2-methylthiazole-5-carboxylate, 95.0%, 5g

(3-Hydroxycyclohexyl)carbamic acid tert-butyl ester, 95.0%, 10g

Pyrimidine-2,4,5,6(1H,3H)-tetraone tetrahydrate, 95.0%, 500g

2-Acetyl-3-fluoropyridine, 95.0%, 25g

NBD-Cl (=4-Chloro-7-nitro-2,1,3-benzoxadiazole) [for HPLC Labeling]>98.0%(T)1g

3-(3-bromophenyl)-6-(piperazin-1-yl)pyridazine, 95.0%, 2g

4-N-Cbz-Aminomethyl-cyclohexanone, 97.0%, 5g

4-Phenyl-1,2-dihydroquinolin-2-one, 100mg

4-Acetyl-3-chlorobenzoic acid, 98%, 250mg